“I’m proud to make my contribution to the KLESIA SomniBrain project […] because sleep disorders have a considerable impact on quality of life and autonomy.”
What’s your background? How did you come to work at Clinatec? and what project are you working on?
After obtaining my baccalaureate, I focused my studies on biology, preparing a bachelor’s degree in physiology and bioengineering, followed by a Master 2 in Integrative and Cognitive Neuroscience at the University of Provence, Marseille. My first professional experiences came during internships at the Institut des Neurosciences de la Timone (INT, Marseille), where I consolidated my skills in behavior and electrophysiology.
My professional career continued as an engineer at the Grenoble Institute of Neuroscience (GIN), involved in the European Neurinox project. I worked on microglia-mediated neuroinflammation in mesiotemporal epilepsy. I then joined the Centre d’Immunologie de Marseille Luminy (CIML) to study stem cell and macrophage biology. After returning to GIN as engineer in charge of a behavioral platform for the GREnoble (GREEN) project, focusing on neurodegenerative diseases, I took charge of setting up and developing this platform. At GIN, I also researched behavioral disorders associated with Parkinson’s disease.
Today, at Fonds Clinatec, I’m reinforcing the photobiomodulation team and working under the supervision of Dr Brigitte Piallat on a pre-clinical model of Parkinson’s disease. Cognitive and motor tests were carried out on Parkinsonian subjects after near-infrared illumination during sleep.
I’m proud to contribute to the KLESIA SomniBrain project. It’s of significant importance to me because sleep disorders have a considerable impact on quality of life and autonomy.